ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,159.00
0.61%
US Tech 100
17,514.00
0.54%
다우존스 지수
38,823.27
0.38%
Bitcoin
64,040.46
0.06%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Kiora Pharmaceuticals Inc (KPRX)

  7. Kiora Pharmaceuticals Inc (KPRX) 뉴스

KPRX Kiora Pharmaceuticals Inc

0.49
-0.0233 (-4.54%)
최종 업데이트: 22:50:30
15분 지연
기업명 주식 심볼 시장 주식 타입
Kiora Pharmaceuticals Inc KPRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.0233 -4.54% 0.49 22:50:30
개장가 저가 고가 종가 전일 종가
0.499 0.471 0.5055 0.5133
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/02/202406:40EDGAR2Form S-3 - Registration statement under Securities Act of..
15/02/202406:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202405:51EDGAR2Form D - Notice of Exempt Offering of Securities
14/02/202410:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202407:23EDGAR2Form 8-K - Current report
10/02/202406:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/02/202400:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/02/202421:01EDGAR2Form 8-K - Current report
01/02/202407:14EDGAR2Form 8-K - Current report
17/01/202407:16EDGAR2Form 8-K - Current report
09/11/202321:02EDGAR2Form 8-K - Current report
09/11/202321:01EDGAR2Form 8-K - Current report
09/11/202321:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202320:05EDGAR2Form 8-K - Current report
14/10/202306:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/10/202305:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/09/202320:00EDGAR2Form 8-K - Current report
01/09/202320:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/09/202320:00EDGAR2Form 8-K - Current report
11/08/202306:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/08/202320:14EDGAR2Form 8-K - Current report
08/08/202320:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/08/202320:00EDGAR2Form 8-K - Current report
22/07/202305:49EDGAR2Form DEF 14A - Other definitive proxy statements
21/07/202306:01EDGAR2Form 8-K - Current report
12/07/202306:00EDGAR2Form PRE 14A - Other preliminary proxy statements
23/06/202321:35GLOBELife Science Investor Forum: Presentations Now Available for..
20/06/202323:58GLOBELife Science Investor Forum Agenda Announced for June 22nd

최근 히스토리

NASDAQ
KPRX
Kiora Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유